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MENTAL STRESS AND TRAUMA 
Mental stress refers to a state of strain and pressure 
on cognitive processes 1. In response, the body alters 
its physiology in order to deal with the stressor. This 
innate mechanism, termed ‘eustress’, is advantageous 
and allows perceived threats to be dealt with imme-
diately  2. However, the long-term exposure to these 
hormones can cause ‘distress’ to the individual, and 
can increase their risk of various physical and mental 
diseases. Mental stress is common and has huge social 
and economic impacts. A commonly experienced daily 
stressor in adults includes workplace stress 3. In 2002, 
the European Union estimated the annual economic 
burden of workplace stress within EU-15 countries 
(including the UK) to be €20 billion. In the US alone, 
workplace stress costs $300 billion annually, when tak-
ing into account factors such as the loss of productivity 
and healthcare costs 4. 
Traumatic events from witnessing or being part of often 
life-threatening situations can also lead to chronic and 
severe stress which, in a small proportion of people, 
can clinically manifest in the form of Post-Traumatic 
Stress Disorder (PTSD) 5. PTSD is a chronic and highly 
debilitating psychiatric disorder which can manifest 
in different ways including flashbacks, avoidance 
Dementia is an increasing global issue, currently affecting an estimated 50 million people worldwide. This num-
ber is predicted to increase to 82 million by the year 2030, due to the ageing global population. Theoretically, 
preventing late-onset dementia may seem extremely difficult as the greatest risk factor, age, is unmodifiable. 
However, it is estimated that a third of dementia cases could potentially be prevented or delayed by removing 
or reducing modifiable risk factors. Increasing evidence suggests that chronic stress, which may arise from 
experiencing a traumatic event or daily stress, may be a potential risk factor for dementia. Whilst it may not play 
a vital role in causing the syndrome, stress may contribute to the progression of cognitive decline, which is the 
main symptom of dementia. The primary stress hormone, cortisol, may have detrimental effects on cognitive 
brain regions when its levels are elevated for long durations. Preliminary evidence suggests that stress may 
have different effects on brain structure and function, depending on the individual’s age when exposed to the 
stress. Stress during early and later life may lead to more permanent brain changes, which may contribute to 
cognitive decline in later life. Limited evidence links chronic stress or major trauma at specific stages of the 
lifespan, with cognitive decline and incidence of dementia. Whether or not an accumulation of stress across 
the lifespan influences later life cognition and risk of dementia, still remains to be determined. Understanding 
to what extent stressful events are risk factors for later-life cognitive decline and dementia will be crucial to the 
implementation of targeted psychosocial interventions efforts. 
Key words: Stress, Trauma, Post-traumatic Stress Disorder, Cortisol, Dementia, Alzheimer’s Disease
The impact of psychological stress and trauma on later-life cognitive function and dementia 115
behaviour and negative alterations in cognition. Com-
mon traumatic events in children under 18 years in-
clude sexual victimisation and witnessing violence  6. 
On a global level, the most common adult traumatic 
events include the unexpected death of a loved one 
and vehicle-related accidents 7. An estimated 28-90% 
of adults in the developed world will encounter at least 
one traumatic event throughout their lifetime. A recent 
analysis of 26 World Health Organisation World Mental 
Health Surveys, across 24 countries, estimated the 
global prevalence of PTSD to be 3.9% 8.
Both stress and traumatic events can have immediate 
and long-lasting negative effects on the brain and can 
alter the structure of regions involved in cognition  9. 
Indeed, there is some evidence to suggest that stress 
and trauma can negatively affect cognitive function, in 
particular when these occur at sensitive periods of the 
life (i.e. critical periods of brain development in child-
hood, and brain decline in old age) or when there is an 
accumulation of stress over the lifetime 10. The effects 
of stress and trauma on cognitive function in later life 
and the risk of dementia, will be the focus of this review. 
MechanisMs of the stress response 
Mental stress elicits a threat to the body’s natural ho-
meostatic processes  2. In response, the body aims 
to restore equilibrium by neutralising this threat with a 
combination of physiological and behavioural respons-
es. Collectively this is known as the “adaptive stress 
response”. The adaptive stress response is mainly 
mediated by two biological mechanisms - the Hypotha-
lamic Pituitary Adrenal (HPA) axis and the sympathetic 
nervous system. Specifically, the HPA axis mediates 
the slow-onset stress response, whilst the sympathetic 
nervous system mediates the acute stress response to 
an immediate danger, otherwise known as the ‘fight or 
flight’ response  11. The mechanisms of both systems 
are outlined in Figure  1, and results in the release of 
stress mediators via the adrenal gland. The HPA axis is 
characterised by the release of corticotropin-releasing 
Figure 1. Short-term and long-term stress response. Shows the mechanisms of the short-term stress response mediated by the 
sympathetic nervous system, and the long-term stress response mediated by the HPA axis. Both responses are regulated by the 
hypothalamus, and result in the release of stress mediators by the adrenal gland. The adrenal cortex releases glucocorticoids in the 
HPA axis pathway, whilst the adrenal medulla releases adrenaline and noradrenaline via the sympathetic nervous system. 
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hormone (CRH) and vasopressin (AVP) by the paraven-
tricular nucleus in the hypothalamus. Both hormones 
promote the secretion of adrenocorticotropic (ACTH) 
from the anterior pituitary to the systemic circulation, 
where it triggers the synthesis and release of the pri-
mary class of stress hormones, glucocorticoids, from 
the adrenal cortex. Glucocorticoids act to redistribute 
energy to enable the body to respond to the actual/
perceived threat  12. These responses include increas-
ing cardiovascular, respiratory, metabolic, and behav-
ioural responses in the body. Similarly, these responses 
are regulated by the short-term stress response – the 
sympathetic nervous system. Nerve impulses from the 
hypothalamus are relayed to the spinal cord, and travel 
through pre-ganglionic fibres to the adrenal medulla 13. 
This results in the release of adrenaline and noradrena-
line noradrenergic neurons in the adrenal medulla 13. The 
HPA axis and sympathetic nervous system also interact 
with each other to trigger the adaptive stress response. 
This joint action is mediated by the corticotropin-
releasing hormone. This is a hormone responsible for 
relaying signals to neurons, which causes the release 
of pro-opiomelanocortin (POMC) in the arcuate nucleus 
of the hypothalamus 14. In turn, this inhibits the sympa-
thetic nervous system. Similarly, noradrenergic neurons 
in the sympathetic nervous system can relay signals to 
the arcuate nucleus to regulate neurons which produce 
corticotropin-releasing hormone. 
coMplications of chronic stress 
The adaptive stress response can be beneficial when 
improving personal performance to overcome short-
term stressful events 2. Contrarily, distress is related to 
chronic stress and results when stress overuses and 
diminishes the integrity of the HPA axis and the sym-
pathetic nervous system. As stress redistributes energy 
to certain tissues, chronic stress may deprive other tis-
sues, leading to detrimental physiological effects. This 
phenomenon is known as allostatic load, or ‘wear and 
tear,’ and can lead to complications such as inflamma-
tion, and may also play a role in cognitive decline  15. 
For example, cortisol, the primary glucocorticoid of the 
human stress response, influences memory in a dose-
dependent fashion 16. Intermediate levels of cortisol has 
been shown to consolidate memory in order to respond 
to the perceived threat. However in high levels, cortisol 
can have a negative effect on cognition 17. 
chronic stress and cognitive brain regions 
There is some evidence that increased levels of cortisol, 
resulting from acute and chronic exposure to stress, are 
negatively associated with cognitive processes includ-
ing learning and memory 16. For example, hyperactivity 
of the HPA system has been observed in those with 
self-reported memory loss  18. It has been suggested 
that increased cortisol may affect cognitive processes 
due to the abundance of glucocorticoid receptors in 
brain regions associated with these cognitive pro-
cesses, including the hippocampus, amygdala and pre-
frontal cortex 19. These are also the main brain regions 
affected in AD and dementia. 
The hippocampus has been well characterised in the 
stress response as it contains the greatest concen-
tration of cortisol receptors within the brain, possibly 
due to its role in regulating the negative feedback 
mechanism of the HPA axis. Its primary role includes 
the formation of long-term memory through processes 
such as long-term potentiation 20. Studies have shown 
a correlation with dysregulated long-term potentiation 
and elevated cortisol, which may result in hippocampal 
atrophy and decreased cognition 21 22. Elevated cortisol 
and hippocampal atrophy have both also been noted 
in AD and dementia  23 24. Imaging studies of patients 
with AD show decreased levels of hippocampal grey 
matter (which is comprised of neuronal cell bodies) 25. 
The greater the severity of the disease, the more pro-
nounced the atrophy. 
These detrimental effects on the hippocampus may 
be explained by the Glucocorticoid Vulnerability Hy-
pothesis 26. This hypothesis suggests that the death of 
hippocampal neurons occurs due to a stress-induced 
dendritic retraction when exposed to elevated gluco-
corticoid levels. Elevated glucocorticoid levels binds 
and downregulates to glucocorticoid receptors to 
activate a negative feedback system which leads to 
a greater release of glucocorticoids  27. An increase in 
glucocorticoids in turn increases extracellular glutamate 
levels, which can have a neurotoxic effect. Thus den-
dritic retraction may occur in hippocampal neurons to 
prevent further exposure to glutamate 26. 
However, this seemingly protective mechanism has a 
downside as retracted dendrites may make the cell 
vulnerable during metabolic events (e.g. ischemia and 
hyperglycaemia) which can occur in the hippocampus, 
leading to cell death 28. Hippocampal damage is greater 
when such metabolic events are introduced after peri-
ods of chronic stress (when glucocorticoid levels are 
elevated for an extended time), than periods of acute 
stress  29. Conrad et al. demonstrated that rats with a 
history of chronic stress induced over 21 days suffered 
from greater hippocampal damage than rats injected 
once with the rodent form of cortisol-corticosterone 29. 
Chronic stress is of particular interest to this study as it 
can be assumed to result from a lifetime accumulation 
of stress and trauma  15. These findings suggest that 
older people are more likely to suffer from hippocampal 
damage in the face of metabolic events. In the case 
of no such metabolic event, cell death is avoided and 
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the dendritic retraction is reversible once glucocorticoid 
levels reduce 29.
Likewise, elevated glucocorticoids also causes revers-
ible dendritic retraction in the prefrontal cortex 30. The 
prefrontal cortex is involved in a wide range of pro-
cesses (e.g. working memory and attention) which are 
required to execute goal-directed behaviour 31. Chronic 
stress is associated with decreased prefrontal cortex 
grey matter, which impairs these functions and its ability 
to interact with the hippocampus to regulate working 
memory 32. Similarly with the hippocampus, atrophy in 
the prefrontal cortex has also been noted in AD and 
dementia 33. 
In addition, chronic stress decreases prefrontal cortex 
regulation of the amygdala, which has a role in the 
formation of emotional memory (when interacting with 
the hippocampus)  34. Unlike in the hippocampus and 
prefrontal cortex, elevated glucocorticoids increases 
activity in the basolateral amygdala and promotes 
dendritic growth in an irreversible manner 35. Thus this 
basolateral hypertrophy is likely to enhance emotional 
memory through an increase in synaptic connections, 
and contribute to the affective symptoms associated 
with stress (e.g. anxiety and depression) 36.
critical periods of brain developMent susceptible 
to stress
The effect of stress on brain regions involved in cogni-
tion is suspected to vary throughout the lifespan 37. It 
has been hypothesised that the most critical periods 
where the brain is most susceptible to damage by 
stress, is in early and later-life 10. Brain regions involved 
in learning/memory are extremely vulnerable to cortisol 
during these life periods, as it is when the brain under-
goes many changes during early-life and in the ageing 
process 38 39. 
Changes to the ageing brain mainly include the reduc-
tion of total brain volume, which decreases at a rate of 
5% per decade after 40 years of age 40. This may result 
from neuronal cell death briefly described in “Section 
3.3”. A reduction in dendritic growth and synapses has 
also been described during the ageing process. Several 
molecular mechanisms have been proposed to explain 
neurodegeneration in ageing. One mechanism includes 
a decline in levels of neurotransmitters such as dopa-
mine 41. In addition, decreased gene expression of vari-
ous components involved in the release of neurotrans-
mitters have also been reported 42. Other mechanisms 
also include mitochondrial dysregulation and reactive 
oxygen species 43. Despite the mechanism involved for 
neurodegeneration, these changes could make the age-
ing brain particularly susceptible to damage by cortisol. 
In terms of early-life, the human brain is not fully de-
veloped at birth. For example, the hippocampus 
undergoes rapid growth until two years of age, and 
more delayed growth until age 14 44. The hippocampus 
also undergoes the most continuous change after birth, 
compared to other regions 44 45. These changes include 
synaptic pruning and dendritic growth 46. The amygdala 
and prefrontal cortex also undergo similar changes dur-
ing childhood. The amygdala undergoes most changes 
during adolescence or sexual maturation 47 48. The pre-
frontal cortex undergoes changes throughout early-life 
and fully matures at age 25 47. 
The effect of stress on these brain regions may in-
duce lasting changes in adulthood  10. Early-life stress 
has been shown to be associated with hippocampal 
atrophy in later life  49. This has been noted in studies 
involving PTSD, although has not been investigated for 
milder forms of stress. A reduction in hippocampal size 
is observed in adults with PTSD related to childhood 
maltreatment, but not observed in children with PTSD 
related to mistreatment  50. This suggests that trauma 
does not cause hippocampal damage immediately, but 
impairs its development over time. However, the age 
in which the trauma occurred can make a difference in 
the type of brain impairments which are accumulated in 
later life. For example, whilst childhood trauma showed 
an association with hippocampal atrophy in adulthood, 
trauma during adolescence showed an association with 
prefrontal cortex atrophy 51. Thus the effect of stress dif-
fers depending on the stage of brain development the 
individual is experiencing. In contrary to the prefrontal 
cortex and hippocampus, early-life stress is associ-
ated with increased amygdala activity 52. For example, 
adults raised in a negative family environment displayed 
greater amygdala activity and decreased cortical activ-
ity in comparison to adults raised by more nurturing 
families 53. 
A number of animal studies also suggests that early-
life stress may induce cognitive deficits in adulthood 38. 
Maternal deprivation is commonly used to show this 
link as disruptions to standard maternal care is the 
main source of early-life stress  54. For example, one 
study showed that maternally deprived rats in early life 
performed worse in cognitive tasks associated with 
the hippocampus in mid-adulthood rather than young 
adulthood  55. Stress induced hippocampal damage 
occurred over-time, with its functional effects seen in 
later-life. However, there are opportunities to reverse 
the effects of early-life stress in the rat model  56. In 
these models, hippocampal volume can be restored 
and cognitive deficits can be reversed, when introduc-
ing pharmacological intervention or social housing to 
maternally deprived pups 57. The possibility to reverse 
the effects of early-life stress has also been observed 
in humans, as supported by observational studies in 
institutionalised children 58. Children raised in nurturing 
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households after being institutionalised performed 
better on cognitive tasks compared to those still being 
institutionalised 59. 
ASSOCIATIONS BETWEEN CHRONIC STRESS, 
COGNITION AND DEMENTIA 
As discussed above, elevated cortisol from chronic 
stress may be associated with the atrophy of brain re-
gions such as the hippocampus and prefrontal cortex. 
This may lead to declined cognition and symptoms 
associated with dementia, as atrophy in these brain 
regions are also observed in AD 60. In addition, elevated 
cortisol levels have been shown to promote an increase 
in AD neuropathology and is also observed in the natural 
ageing process 61. The strongest evidence is observed 
in animal studies. In mouse models of AD and in vitro 
studies, elevated levels of glucocorticoids are associ-
ated with an increased expression of amyloid precur-
sor protein and β-secretase, thus shifting the amyloid 
precursor protein processing towards the pathogenic, 
amyloidogenic pathway 62. This glucocorticoid-induced 
increase in the amyloidogenic pathway and hence amy-
loid plaques, is suggested to influence downstream tau 
pathology and the formation of neurofibrillary tangles 63. 
Further animal studies also show evidence to sug-
gest that elevated amyloid precursor protein, amyloid 
plaques, and abnormal tau are linked with cognitive 
impairment through the process of neuronal death and 
synaptic dysfunction in brain areas involved in learn-
ing and memory 64. Cortisol may interact with amyloid 
plaques and further exacerbate cognitive impairment 
in learning than amyloid deposits alone, regardless of 
other factors 65.
These animal studies are consistent with the lim-
ited findings of studies in humans which suggest that 
chronic stress and elevated cortisol is associated with 
negative effects on both cognitive outcomes and risk 
of AD. This is best illustrated by two large-scaled and 
prospective longitudinal studies, which are most ideal 
to determine this association. The first study by Jo-
hansson et al. analysed a Swedish female population 
(n = 1415) over 35 years  66. Participants were asked 
to self-report frequent stress in the last 5 years at 3 
time points. Diagnosis of dementia subtype by neu-
ropsychiatric examination was also performed at each 
of these time points. Various potential risk factors for 
dementia (e.g. smoking and socioeconomic status) 
were adjusted for in their analyses. They found an as-
sociation between self-reported frequent stress during 
mid-life, and an increased likelihood of both early and 
late onset dementia. In particular, the incidence of de-
mentia increased according to the amount of times the 
participants reported stress at the three different time 
points. Participants who reported frequent stress at all 
3 time points had a greater likelihood of developing de-
mentia (particularly AD) than participants who reported 
stress at only 2 or 1 time points (HR = 2.7, 1.7, 1.1 re-
spectively). This supports the notion that chronic stress 
across the lifespan may be a risk factor for dementia. 
However, there are some limitations to consider. Firstly, 
the study cannot be generalisable to the male popula-
tion, despite dementia being more prevalent in the fe-
male population 67. In addition, the study focused solely 
on the frequency of common everyday stress and did 
not take into account more severe stress (e.g. arising 
from traumatic events). To date, there are no longitudi-
nal studies which combine both common and severe 
stressors, to investigate the association between stress 
and incidence of dementia. 
The second longitudinal study investigated morning 
plasma cortisol levels across a period of 6 years as a 
marker for chronic stress  68. This prospective cohort 
study (n  =  416) observed cognitively normal adults 
over the age of 60 with preclinical AD, as identified by 
the presence of high levels of amyloid plaques via neu-
roimaging techniques. Likewise to the previous study, 
various potential risk factors for AD were accounted 
for in their analyses. Their results found that adults 
with preclinical AD and high plasma cortisol levels, 
had lower cognitive scores than adults with preclinical 
AD and low plasma cortisol levels, across the 6 year 
period. This supports the notion that chronic stress, 
which is related to elevated cortisol over a significant 
duration (6 years), is only associated with cognitive 
decline in the presence of AD neuropathology. This 
also supports animal findings that cortisol accelerates 
cognitive decline associated with AD 65. However, un-
like the previous study, this study cannot be general-
ised to other types of dementia. A second limitation 
to this study, is that cortisol levels were only collected 
in the morning across the 6 year period. Cortisol lev-
els naturally fluctuate throughout the day in order to 
regulate the wake-sleep cycle, with its level highest in 
the early morning 69. Diurnal collection of cortisol may 
have produced more accurate results. 
The role of cortisol in AD has also been observed in 
post-mortem studies, which is the only method, to 
date, that can provide an accurate diagnosis of AD 70. 
One study observed significant increases in cortisol col-
lected from cerebrospinal fluid after death, in early-on-
set AD patients, compared to age matched controls 71. 
Interestingly, this association was not observed in late-
onset AD patients compared to their age matched con-
trols. This may be due to the natural increase of cortisol, 
with age, even in the absence of dementia, and may 
explain the normal decline in cognition in the elderly 72. 
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The HPA axis naturally increases in activity with age 73. 
Several studies indicate that diurnal cortisol levels are 
significantly higher in older adults  17. Cortisol may fa-
cilitate cognitive decline in the normal ageing process, 
as neuroimaging studies indicate similar changes to 
the brain in AD and ageing 74. In ageing, there is grey 
matter reduction in the hippocampus and prefrontal 
cortex, with the majority comprising of prefrontal cortex 
atrophy 74. In addition, a reduction in synaptic density 
has been noted in structures associated with cogni-
tion. These changes to brain structures are present in 
both the normal ageing process, and in early-onset AD 
which is independent of old age 75. Thus, these findings 
suggest that cortisol facilitates cognitive decline in both 
situations. 
Further human evidence linking stress with dementia 
and cognitive decline, include studies of PTSD popula-
tions. As mentioned earlier, PTSD is a disease charac-
terised by chronic stress. In a large-scaled retrospective 
cohort study of 181,093 US veterans over 55 years, 
veterans diagnosed with PTSD were found to be more 
than twice as likely to develop dementia, than veterans 
without PTSD 76. However it is important to note that 
PTSD is a unique, clinically significant condition that is 
diagnosed according to a set criteria 77. These findings 
may not be directly applicable to either chronic or acute 
stress in the absence of a clinical PTSD diagnosis. 
However, due to the similar physiological responses in 
PTSD and chronic stress, they may be more applicable 
to chronic than acute stress 78. In addition, both PTSD 
and dementia observe similar structural changes to 
the brain such as hippocampal and prefrontal cortex 
atrophy 79. It is not yet determined if structural changes 
in both diseases are due to common risk factors. This 
study adjusted for some known risk factors e.g. low 
education levels. However, as there are further risk fac-
tors yet to be identified in both PTSD and dementia, an 
unconfounded causal link cannot be accurately estab-
lished. 
Similar associations between trauma and dementia 
have been observed in the Aboriginal Australian popu-
lation, which have reported both higher exposure to 
stressful events (especially childhood trauma), and 
higher rates of dementia 80. A cross-sectional study by 
Radford et al. surveyed 336 Aboriginal and Torres Strait 
Islander participants aged 60-92 years regarding the 
frequency of their childhood trauma, using a validated 
childhood trauma questionnaire. All-cause dementia 
and AD were both diagnosed clinically, in adherence 
with the National Institute on Aging-Alzheimer’s As-
sociation criteria  81. Higher frequencies of childhood 
trauma were associated with an increased risk of all-
cause dementia (OR = 1.70, 95% CI 1.14-2.54) and AD 
(OR = 1.77, 1.08-2.91) 80. These findings suggest that 
early-life trauma may contribute to dementia in later-life. 
This may be due to the vulnerability of the developing 
brain to cortisol, which may lead to lasting changes (as 
discussed in Section 3.4). However, the strongest evi-
dence would ideally be derived from larger-scaled and 
prospective longitudinal studies following participants 
from childhood to adulthood. Due to time and financial 
constraints, such studies may not be feasible. Current 
longitudinal prospective cohort studies recruiting in 
mid-adulthood are likely to have too few participants 
with the development of dementia at present. Further-
more, longitudinal prospective cohort studies tend to 
focus on chronic diseases which are of high burden at 
the initiation of the cohort and as dementia is a relatively 
new burden. Finally, the effects of stress on health is a 
relatively new concept, and therefore longitudinal pro-
spective cohort studies that undertook recruitment 15 
years ago are unlikely to have a measure at baseline. 
These factors contribute to the lack of evidence regard-
ing stress as a risk factor for dementia. No studies to 
date have investigated if not only early-life trauma, but 
the accumulation of stress and trauma across the lifes-
pan, is associated with later-life dementia and cognitive 
decline. 
CONCLUSIONS
There is an accumulation of evidence which links 
chronic stress or major trauma at specific stages of the 
lifespan with impairments in cognitive function. How-
ever whether or not an accumulation of stress over the 
lifetime influences later life cognition and the dementia 
risk (as well as the age of onset), remains to be deter-
mined.
Understanding to what extent stressful events are risk 
factors for later-life cognitive decline and dementia, as 
well as potentially modifiable factors which can help 
reduce this risk, will be crucial to the implementation 
of psychosocial interventions targeted on an individual 
basis (given a person’s place of residence, social 
support and family networks). Delaying the onset and/
or progression of dementia or helping an individual to 
maintain independence as long as possible, will be 
beneficial to the individual, their family, carers and the 
wider community.
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